Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures
39
Zitationen
3
Autoren
2010
Jahr
Abstract
Four hundred and fifty patients with an open tibial fracture were randomized to receive either intramedullary nail fixation and routine soft-tissue management only, or with the addition of an implant containing either 0.75 mg / mL or 1.50 mg / mL of recombinant human bone morphogenetic protein-2 (rhBMP-2). In this study, the use of 1.50 mg / mL of rhBMP significantly reduced the number and invasiveness of secondary procedures, accelerated fracture and wound healing, and reduced the rates of infection, hardware failure, and overall pain.
Ähnliche Arbeiten
ISB recommendation on definitions of joint coordinate systems of various joints for the reporting of human joint motion—Part II: shoulder, elbow, wrist and hand
2004 · 4.453 Zit.
Risk Factors for Hip Fracture in White Women
1995 · 3.581 Zit.
Burden of major musculoskeletal conditions.
2003 · 3.532 Zit.
Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones
1976 · 3.256 Zit.
de la Chapelle, A.
1997 · 3.167 Zit.